The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin

L Minchiotti1, M Galliano, P Iadarola

  • 1Department of Biochemistry, University of Pavia, Italy.

Insights

Albumin Venezia, a human serum albumin variant, has a shortened chain due to exon 14 deletion. This genetic defect impacts albumin stability, affecting protein levels in circulation.

Area of Science:

  • Biochemistry
  • Human Genetics
  • Molecular Biology

Background:

  • Albumin Venezia is a fast migrating genetic variant of human serum albumin.
  • In heterozygous individuals, it constitutes approximately 30% of circulating protein.

Purpose of the Study:

  • To investigate the molecular defect of albumin Venezia.
  • To analyze the variant in a subject with an atypical level (80%) and family members.

Main Methods:

  • Serum albumins were isolated and treated with cyanogen bromide (CNBr).
  • Resulting fragments were analyzed by isoelectric focusing.
  • Peptides were purified using reverse-phase high-performance liquid chromatography and sequenced.

Main Results:

  • Albumin Venezia has a shortened polypeptide chain (578 instead of 585 residues).
  • Extensive modification from residue 572 to the COOH-terminal end suggests exon 14 deletion and translation into exon 15.
  • Absence of a basic COOH-terminal dipeptide is likely due to carboxypeptidase N action.

Conclusions:

  • The genetic defect in albumin Venezia involves a shortened polypeptide chain and altered COOH-terminus.
  • Carboxypeptidase N action may contribute to the observed molecular modifications.
  • The low serum level of the variant suggests the COOH-terminal end is critical for albumin stability.

Related Concept Videos

Mutations01:39

Mutations

Overview
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Protein Denaturation01:28

Protein Denaturation

The function of proteins depends on their native three-dimensional structure, which is dictated by the amino acid sequence of the specific protein. Folding of the polypeptide chain takes place under specific conditions that energetically favor the folded conformation. In contrast, protein denaturation occurs spontaneously under unfavorable conditions that disrupt the integrity of the folded conformation. Thus, the chemical and physical environment of a protein, such as significant changes in pH...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...